Dr. Abbey Discusses Latest Dry AMD Treatment Research on New Podcast Episode
While anti-VEGF injections are widely used to treat patients with wet age-related macular degeneration (AMD), there have been limited treatment options available for dry AMD other than AREDS vitamin formulations and lifestyle
read more
Understanding Your Insurance Coverage in the New Year: How Prior Authorizations Can Impact Retina Care
Health insurance policies and coverage vary greatly. As we start a new year, it is important to understand how your specific plan works and how that can affect your retina care. Referrals
read more
Office Closures for 1/10/2025
Due to the winter weather, the following Texas Retina offices are CLOSED today, January 10, 2025: Dallas North Athens Denton Grapevine Mansfield Sherman Wichita Falls If you have an appointment scheduled that
read more
Winter Weather Closures
Due to the winter weather, the following Texas Retina offices are CLOSED today, January 9, 2025: Dallas North Arlington Athens Frisco Denton Fort Worth Grapevine Plano Sherman Wichita Falls If you have
read more
Dr. Anand Participated in Research on New Gene Therapy Drug for X-linked Retinitis Pigmentosa Published in American Journal of Ophthalmology
The two-year results of the Phase I/II, multi-center HORIZON clinical trial of the new subretinal gene therapy drug AGTC-501 for X-linked retinitis pigmentosa were recently published in the American Journal of Ophthalmology.
read more
2025 New Year’s Resolutions for Your Eyes
As 2025 begins, it is the perfect time to commit to living a healthy lifestyle. Here are eight New Year’s resolutions to improve your eye health and protect your vision: 1. Schedule
read more
Dr. Abbey Reports on New Method to Measure Retinal Fluid After Treatment with Faricimab for Wet AMD
Texas Retina’s Ashkan M. Abbey, MD, recently co-authored an article in the medical journal Eye on the use of a novel deep-learning algorithm to quantify retinal fluid changes in patients treated with
read more
Dr. Abbey Presented at the Outpatient Ophthalmic Surgery Society (OOSS) Symposium 2024
Texas Retina’s Ashkan Abbey, MD, recently presented “Innovation in Retina for the ASC” at the Outpatient Ophthalmic Surgery Society (OOSS) Symposium 2024. He highlighted the advantages and disadvantages of several recent surgical
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood vessels all over the body, including
read more
Dr. Abbey Doses First Patient in Phase III LUGANO Clinical Trial of Duravyu for Wet AMD
Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, recently dosed the first patient in the Phase III LUGANO clinical trial of Duravyu (formerly EYP-1901) for the treatment of
read more